Schulten Andre 4
4 · PROCTER & GAMBLE Co · Filed Oct 2, 2025
Insider Transaction Report
Form 4
Schulten Andre
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-10-01+77,648→ 77,648 totalExercise: $153.18From: 2028-09-29Exp: 2035-10-01→ Common Stock (77,648 underlying) - Award
Common Stock
2025-10-01+5,602→ 58,244.027 total
Holdings
- 6,870.655(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Restricted Stock Units awarded pursuant to The Procter & Gamble 2019 Stock and Incentive Compensation Plan.
- [F2]Reflects adjustment to PST through September 30, 2025.